Opening book details…
About this Medicine article
Costs of Managing Adverse Events in the Treatment of First-line Metastatic Renal Cell Carcinoma: Bevacizumab in Combination with Interferon-α2a Compared with Sunitinib by Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M
- Publisher
- Nature Publishing Group; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0007-0920)
- Published
- 2009
- Field
- Medicine (Health Sciences)
More by Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M
Browse all works by Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M